AstraZeneca vaccine has higher efficacy against COVID-19 with a three-month gap between doses, says Oxford study
The study, published in The Lancet, suggests that the interval between doses can be safely extended to three months than a six-week gap as the first dose can offer up to 76 percent protection during that period
WHO clears AstraZeneca's COVID-19 jab for emergency use; world body to begin delivery of millions of doses
WHO's green light for the AstraZeneca vaccine is only the second one the UN health agency has issued after approving the Pfizer-BioNTech vaccine in December
The study sought to examine whether someone inoculated could still acquire the virus without getting sick and spread it to others
Several European countries have already restricted the use of the vaccine developed by Oxford to younger adults only, despite approval from the EU medicines agency for all ages
Over 160 L COVID-19 vaccine doses procured so far, but beneficiaries below target due to hesitancy, govt tells LS
Giving out the details of the number of vaccines already procured by the government, Minister of State for Health Ashwini Choubey said the total cost of procurement of above mentioned doses of vaccines is Rs 350.25 crore
Multiple countries have advised against administering the Oxford-AstraZeneca vaccine to the elderly population.
France's health advisory body recommends giving AstraZeneca's COVID-19 vaccine only to people under 65
The French guidance differs from that given by the European Medicines Agency, which authorized AstraZeneca's vaccine for use in all adults throughout the European Union
Germany threatens legal action as tensions rise between EU and AstraZeneca over COVID-19 vaccine delays
AstraZeneca has said that for now it can only deliver a quarter of the doses originally promised to the EU for the first quarter of the year because of issues at one of its European factories
While the court order was not available immediately, the lawyer of Cutis-Biotech, which had filed the suit, said it would file an appeal in the Bombay High Court
There is hard evidence that fractional doses and delayed doses have worked when doctors have tried them out of desperation.
Earlier reports said that the AstraZeneca/Oxford vaccine efficacy is as low as eight percent in adults over 65 years.
Doses of the vaccine, Covishield, will initially be shipped to 60 consignee points and will then be distributed to various vaccination centres across India
Centre buys 11 mn doses of Covishield; Narendra Modi calls COVID-19 vaccines made in India 'most cost-effective'
The country also recorded the lowest daily spike in cases and deaths in nearly eight months, the Union health ministry said on Monday
Coronavirus News Updates: Bharat Biotech says Bhopal volunteer who died 10 days after trial jab was 'healthy' in follow-ups
Coronavirus News LIVE Updates: A 42-year-old volunteer from Bhopal died nearly ten days after he participated in the clinical trial for Covaxin; poisoning is suspected but officials said that the exact cause of the death will be known after viscera test
Coronavirus News LIVE Updates: In trials with more than 30,000, the Moderna vaccine offered nearly 95 percent protection from severe COVID-19
'I don't trust them': Ayatollah Ali Khamenei bans import of Pfizer, AstraZeneca COVID-19 vaccines in Iran
Khamenei’s statement reflects decades of tense relations between Iran and the West which have not abated in the waning days of Donald Trump’s presidency
Coronavirus News Updates: Three more in Maharashtra test positive for UK COVID-19 strain, state's tally now 11
Coronavirus News Updates: A state health official said the three new patients are from Pimpri Chinchwad Municipal Corporation area near Pune city. All 11 patients are asymptomatic, he added
Coronavirus News Updates: Delhi's tally of patients with new COVID-19 strain rises to 9; no UK variant in Mizoram, says health minister
Coronavirus News Updates: Mizoram health minister Dr R Lalthangliana said seven state residents have so far returned from the United Kingdom and all of them tested negative for the mutant coronavirus as well as COVID-19
Coronavirus News Updates: Centre should bear cost of COVID-19 vaccine for the poor, says Rajesh Tope
Coronavirus News Updates: The Maharashtra health minister said two doses (of a COVID-19 vaccine) will cost Rs 500 and the state government will take "appropriate" steps if the Centre doesn't take steps regarding its expectation
Unlike the Pfizer and Moderna which requires a minus 70 degree Celsius (cold) chain, most Indian vaccine candidates have been designed to work at storage temperatures of 2-8 degrees Celsius due to logistical issues